Episode 7: Clinical Trials
New Ways to Detect and Treat NETs
What are clinical trials? In this episode of NETWise, discover how new ideas in NET detection and treatment are moving from the laboratory to the bedside. You’ll learn about the different stages of research and how promising drug compounds progress through them.
You will also learn how clinical trials determine whether new or improved treatments are safe and effective and work better than current therapies.
Have you ever thought about joining a clinical trial? You will hear from NET specialists like Drs. Satya Das, Daniel Halperin, Renuka Iyer, Pam Kunz, Nitya Raj, and Diane Reidy-Lagunes about how patients can talk to their care team about participating in a clinical trial. This episode will also dispel some common clinical trial myths about taking placebos and eligibility requirements. We hear from NET patient advocate Josh Mailman about some of the existing problems accessing clinical trials and what we can do to overcome these barriers.
After you listen to this episode, you will have a better understanding of how clinical trials work, why they are essential, and how you can talk to your care team about your participation options.
Use our episode infographics to get a visual picture of some of the things we have discussed.
Clinical trials: See the phases of clinical trials and how they differ in the process to develop and test new treatments.
Mentioned in this Episode:
Therapies for Neuroendocrine Tumors
VIDEO: Clinical Trials – What Are They and Who Should Enroll – Dr. Pamela Kunz, Yale University
VIDEO: Understanding Clinical Trials – Dr. Renuka Iyer, Roswell Park Cancer Institute
VIDEO: Immunotherapy for NETs – Dr. Pamela Kunz, Yale University
ADDITIONAL NET RESEARCH FOUNDATION RESOURCES:
Request a Mailed Copy of our Neuroendocrine Cancer Guide
Get in touch:
Email questions or feedback to podcast@netrf.org. Find us on Facebook and Twitter, YouTube.